Dagga firm Cilo Cybin prepares for clinical trials in SA as it again eyes JSE listing

The Best of 702 Weekend Breakfast - Un pódcast de 702 - Domingos

Categorías:

CEO of Cilo Cybin, Gabriel Theron on the future of medical cannabis business in SA, what it takes to list a Dagga firm and looking ahead to Cilo Cybin's eminent JSE listing, as the company has now won the backing of Malaysian biotechnology group, ALPS global, which has acquired a 10% stake.See omnystudio.com/listener for privacy information.

Visit the podcast's native language site